HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma
出版年份 2017 全文链接
标题
HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma
作者
关键词
-
出版物
LEUKEMIA
Volume 32, Issue 3, Pages 703-711
出版商
Springer Nature
发表日期
2017-11-14
DOI
10.1038/leu.2017.299
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma
- (2016) Ichiro Fukumoto et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Activated Transcription Factor 3 in Association with Histone Deacetylase 6 Negatively Regulates MicroRNA 199a2 Transcription by Chromatin Remodeling and Reduces Endothelin-1 Expression
- (2016) Chen Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Expression and function of microRNA-27b in hepatocellular carcinoma
- (2016) SHUJIE HE et al. Molecular Medicine Reports
- Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines
- (2016) Zong-yang Li et al. NEUROCHEMICAL RESEARCH
- MicroRNA-27b suppresses Helicobacter pylori-induced gastric tumorigenesis through negatively regulating Frizzled7
- (2016) YAN GENG et al. ONCOLOGY REPORTS
- MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma
- (2016) Xin-Fang Sun et al. TUMOR BIOLOGY
- Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death
- (2015) Yuko Mishima et al. BRITISH JOURNAL OF HAEMATOLOGY
- MicroRNA-27b suppresses tumor progression by regulating ARFGEF1 and focal adhesion signaling
- (2015) Rei Matsuyama et al. CANCER SCIENCE
- BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs
- (2015) Z. Liu et al. CLINICAL CANCER RESEARCH
- Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma
- (2015) J. E. Amengual et al. CLINICAL CANCER RESEARCH
- Drug-releasing mesenchymal cells strongly suppress B16 lung metastasis in a syngeneic murine model
- (2015) Augusto Pessina et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1
- (2015) Ryou-u Takahashi et al. Nature Communications
- Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients
- (2015) Emilia L Lim et al. GENOME BIOLOGY
- Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells
- (2014) Ning Ding et al. Cancer Cell International
- NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
- (2014) Lina Odqvist et al. MODERN PATHOLOGY
- In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells
- (2014) G. Dasmahapatra et al. MOLECULAR CANCER THERAPEUTICS
- The effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanisms
- (2013) Ying Cai et al. Cancer Cell International
- MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas
- (2013) Sang Y Ha et al. MODERN PATHOLOGY
- Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes
- (2013) J.H. Wang et al. OSTEOARTHRITIS AND CARTILAGE
- Functional cooperation of miR-125a, miR-125b and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells
- (2013) S Wang et al. Cell Death & Disease
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
- (2012) B. M. Slomovitz et al. CLINICAL CANCER RESEARCH
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors
- (2009) Annunziata Gloghini et al. BRITISH JOURNAL OF HAEMATOLOGY
- Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas
- (2009) Lena Marquard et al. HISTOPATHOLOGY
- Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase–2 and –7 and E-cadherin
- (2009) Yasuyoshi Miyata et al. HUMAN PATHOLOGY
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: Pathological significance in early- and late-onset breast carcinoma
- (2008) Satyabrata Sinha et al. Molecular Cancer
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
- (2008) Witold Filipowicz et al. NATURE REVIEWS GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now